WallStSmart

Welltower Inc (WELL)vsWeyerhaeuser Company (WY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 86% more annual revenue ($12.76B vs $6.85B). WELL leads profitability with a 12.1% profit margin vs 6.9%. WY appears more attractively valued with a PEG of 1.35. WY earns a higher WallStSmart Score of 57/100 (C).

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20

WY

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 4.5Value: 4.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$235.62

$109.65 premium

UndervaluedFair: $125.97Overvalued
WYSignificantly Overvalued (-29.2%)

Margin of Safety

-29.2%

Fair Value

$20.97

Current Price

$22.06

$1.09 premium

UndervaluedFair: $20.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

WY2 strengths · Avg: 9.0/10
EPS GrowthGrowth
87.1%10/10

Earnings expanding 87.1% YoY

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

WY4 concerns · Avg: 3.3/10
P/E RatioValuation
34.4x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.0%3/10

ROE of 5.0% — below average capital efficiency

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bull Case : WY

The strongest argument for WY centers on EPS Growth, Price/Book. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Bear Case : WY

The primary concerns for WY are P/E Ratio, Return on Equity, Profit Margin.

Key Dynamics to Monitor

WELL profiles as a growth stock while WY is a value play — different risk/reward profiles.

WY carries more volatility with a beta of 0.89 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 57/100) and 39.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Weyerhaeuser Company

REAL ESTATE · REIT - SPECIALTY · USA

Weyerhaeuser Company is an American timberland company which owns nearly 12,400,000 acres of timberlands in the U.S. and manages an additional 14,000,000 acres timberlands under long-term licenses in Canada. The company also manufactures wood products. Weyerhaeuser is a real estate investment trust.

Visit Website →

Want to dig deeper into these stocks?